United States
        Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a BioSpace LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.
    
        
    
        
    
        
    
        Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
    
        
    
        
    
        
    
        Genentech is letting go of 118 employees in South San Francisco. The news comes about two months after the biotech ended a partnership with Adaptive Biotechnologies.
    
        
    
        
    
        
    
        Executives from Eli Lilly, Merck and other companies foresee the FDA’s new onshoring proposal being anything from a bureaucratic waste of time to a transformative program that will eliminate inspection-related complete response letters.
    
        
    
        
    
        
    
        Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
    
        
    
        
    
        
    
        Looking for a job in regulatory? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
    
        
    
        
    
        
    
        Due largely to CSL, Merck and Novo Nordisk’s reorganizations that could total about 19,350 people, Q3 cuts rose significantly year over year and quarter over quarter, based on BioSpace tallies.
    
        
    
        
    
        
    
        Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
    
        
    
        
    
        
    
        Looking for a biopharma job in Boston? Check out the BioSpace list of six companies hiring life sciences professionals like you.
    
        
    
        
    
        
    
        As major pharmas pull away from the U.K. and the U.S. risks ceding its lead through a national brain drain, the U.K. must create a new, more robust model for innovation.
    
        
    
        
    
        
    PRESS RELEASES
        
        
        
     
         
 
 
 
 
 
 
 
 
